Welcome to AdvanceTech Monitor

Featured products

See details Pricing and Reimbursement Strategies for Diagnostics: Overcoming reimbursement issues and navigating the regulatory environment Reimbursement for diagnostics is the key requirement for both the diagnostic providers and the payers because while 5-7% of the hospital cost is incurred on diagnostics, they are used for around 70% of the healthcare decisions. This top-selling report identifies novel pricing strategies to maintain a fair plane among all the stakeholders with this report. Our price: $ 3,835.00 See details Opportunities in Orphan Drugs: Strategies for developing maximum returns from niche indications Orphan drugs present opportunities to pharma companies looking to move into more niche indications and away from mass market indications that have very low levels of clinical unmet need. Although there are many successful orphan drugs that have made large profits for their developers (Gleevec, NovoSeven etc) the development of these products must be approached carefully. This report uses a mixture of case studies and data from secondary sources to elucidate the key issues in the development of orphan drugs and ways to navigate them. Our price: $ 3,835.00